Samsara Biocapital, LLC
CIK:0001744967
Venture Capital
$2B AUM
29 holdings
Palo Alto, CA, USA
Samsara BioCapital is a venture capital firm focused on healthcare and biotechnology investments.
Investment Strategy
Venture capital investments in healthcare and biotechnology companies
Top Buys
S
SRRKSCHOLAR ROCK HLDG CORP+$18.4M
S
SEPNSEPTERNA INC+$15.1M
A
AURAAURA BIOSCIENCES INC+$6.3M
N
NGNENEUROGENE INC+$5.6M
J
JBIOJADE BIOSCIENCES INC+$5.3M
Top Sells
K
KLRSKALARIS THERAPEUTICS INC-$61.4M
M
MLYSMINERALYS THERAPEUTICS INC-$13.3M
P
PVLAPALVELLA THERAPEUTICS INC NE-$11.4M
S
SLRNACELYRIN INC-$6.2M
A
ALMSALUMIS INC-$5.7M
Top Holdings
S
SRRKSCHOLAR ROCK HLDG CORP+40.7%$198.8M
M
MLYSMINERALYS THERAPEUTICS INC+15.7%$76.8M
S
SEPNSEPTERNA INC+6.8%$33.3M
K
KLRSKALARIS THERAPEUTICS INC+6.3%$30.6M
N
NGNENEUROGENE INC+5.3%$25.7M
Equity Positions (29)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
S SRRK | SCHOLAR ROCK HLDG CORP | 40.66% | $198.8M | 5,612,896 | $10.15 | $35.42 | +$18.4M |
M MLYS | MINERALYS THERAPEUTICS INC | 15.70% | $76.8M | 5,674,916 | $15.43 | $13.53 | -$13.3M |
S SEPN | SEPTERNA INC | 6.81% | $33.3M | 3,149,128 | $20.83 | $10.57 | +$15.1M |
K KLRS | KALARIS THERAPEUTICS INC | 6.25% | $30.6M | 11,448,081 | $8.03 | $2.67 | -$61.4M |
N NGNE | NEUROGENE INC | 5.25% | $25.7M | 1,717,127 | $20.29 | $14.95 | +$5.6M |
Industry Allocation
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+50.1%
PHARMACEUTICAL PREPARATIONS
+43.4%